A1. Novel Agents
Poster Session: Novel Agents
Yoshinori Yamano, PhD (he/him/his)
Chief Scientific Officer for Infectious Diseases
Shionogi & Co., Ltd.
Toyonaka, Osaka, Japan
Boudewijn L. DeJonge, PhD
Director Microbiology
Shionogi Inc.
Florham Park, NJ, United States
Sean T. Nguyen, PharmD
Director, Medical Affairs
Shionogi Inc.
Florham Park, NJ, United States
Jason Bryowski, PharmD
Shionogi Inc.
Florham Park, New Jersey, United States
Joshua Maher, PhD
Element Materials Technology/Jones Microbiology Institute
North Liberty, Iowa, United States
Rodrigo E. Mendes, PhD (he/him/his)
Director
Element Iowa City (JMI Laboratories)
North Liberty, IA, United States
Hidenori Yamashiro
subgroup leader
Shionogi & Co., Ltd.
Toyonaka, Osaka, Japan
Christopher M. Longshaw, PhD
Senior Director, Scientific Affairs EU
Shionogi B.V.
London, England, United Kingdom